IMMUNOGENIC PROPERTIES AND MOLECULAR-GENETIC FEATURES OF NATIVE AND INACTIVATED CHLAMYDIA TRACHOMATIS MT-2A SEROVARIANT D STRAIN


Cite item

Full Text

Abstract

Aim. Study of antibody genesis after introduction of native and inactivated Chlamydia trachomatis МТ-2А strain into Balb/c mice and analysis of molecular-genetic features of omp A gene that is responsible for its immunogenicity. Materials and methods. Chlamydia infection was modeled in Balb/c mice by using human isolated C.trachomatis serovariant D. Results. After the introduction of this strain, 5 days after the infection of mice A, M and G class antibodies including G class antibodies against chlamydia heat shock protein are induced. Studies of molecular-genetic features of the isolated C.trachomatis МТ-2А strain showed presence of 2 nucleotide mutations in ompA gene. A synonymous substitution of cytosine to thymine in position 574 (CD) that does not result in amino acid substitution in the protein was registered. A non-synonymous substitution of thymine to guanine was present in position 843 (VDIII), that is most probably one of the main reasons of the registered higher immunogenicity of C.trachomatis МТ-2А serovariant D strain. Conclusion. Further studies of C.trachomatis МТ-2А serovariant D strain are promising, but do not exclude search of other immunogenic strains for the generation of agents for specific prophylaxis and immunotherapy of chlamydiosis.

About the authors

N. N Poleschuk

Republican Scientific Practical Center of Epidemiology and Microbiology, Minsk, Belarus

L. V Rubanik

Republican Scientific Practical Center of Epidemiology and Microbiology, Minsk, Belarus

N. N Kapitulets

Republican Scientific Practical Center of Epidemiology and Microbiology, Minsk, Belarus

C. A Kostyuk

Belarussian Medical Academy of Postgraduate Education, Minsk, Belarus

E. V Barkovsky

Belarussian State Medical University, Minsk, Belarus

References

  1. Кулага О.К., Костюк С.А., Полещук Н.Н. и др. Моделирование хламидийной инфекции гениталий (экспериментальное исследование). Мед. нов. 2007, 12: 97-100.
  2. Полещук Н.Н, Капитулец Н.Н., Рубаник Л.В. и др. Особенности обнаружения и механизмы персистенции возбудителя Chlamydia trachomatis. Там же. 2003, 3: 65-70.
  3. Полещук Н.Н., Рубаник Л.В., Капитулец Н.Н. и др. Биологические и иммуногенные свойства штамма Chlamydia trachomatis МТ-2А (серовар D) и его использование для разработки экспериментальной инактивированной вакцины. Журн. микробиол. 2008, 3: 39-44.
  4. Рубаник Л.В. Механизмы противохламидийного иммунитета и конструирование противохламидийной вакцины. Мед. нов. 2006, 11: 29-34.
  5. Хворик Д.Ф., Цыркунов В.М., Полещук Н.Н. и др. Формирование иммунитета при хламидийной урогенитальной инфекции в эксперименте. Здравоохранение. 2008, 9: 61-64.
  6. Ito J.I., Lyons J.M., Airo-Brown L.P. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. IAI. 1990, 58 (6): 2021-2023.
  7. Khrustalev V.V. Can Mutational GC-perssure create new linear B-cell epitopes in Herpes simplex virus type 1 glycoprotein B? Immun. Invest. 2009, 38 (7): 613-623.
  8. Lyons J.M, Morre S.A., Airo-Brown L.P. et al. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice. J. Microbiol. Immunol. Infect. 2005, 38: 383-393.
  9. Ramsey K.H., Newhall W.J., Rank R.G. Humoral immune response to Chlamydial genital infection of mice with the agent of mouse pneumonitis. IAI. 1989, 57 (8): 2441-2446.
  10. Sangare L., Morisset R., Gaboury L., Ravaoarinoro M. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice. J. Antimicrob. Chemother. 2001, 47: 323-331.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Poleschuk N.N., Rubanik L.V., Kapitulets N.N., Kostyuk C.A., Barkovsky E.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies